US FDA Provides Guidance on Remote Interactive Evaluations for Oversight of Drug Facilities During COVID-19

The US Food and Drug Administration (FDA) announced the availability of a guidance document entitled, “Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency” for the Oversight of Drug Facilities
Subscribe to Company and Product News